Grace Vandal

Grace Vandal currently serves as the Executive Director of Alliance and Program Management at Zentalis Pharmaceuticals, a position held since April 2023. Prior to this, Grace worked at Arvinas as a Development Team Lead from June 2020 to January 2023, where cross-functional teams were established to advance the company’s first clinical stage programs through Phase 1 and 2 into Phase 3 readiness. Grace's extensive career at Pfizer spanned over twelve years in various project management roles, culminating as Senior Director of Project Management within the Oncology Therapeutic Area, managing development teams for multiple drug compounds. Additional roles at Pfizer included oversight of projects in Neuroscience and Inflammation, as well as earlier experience as an Analytical Chemist. Grace’s educational background includes a B.S. in Chemistry and an M.B.A. from the University of Rhode Island, along with MSc degrees in Quality Assurance/Regulatory Affairs from Temple University and Chemical Oceanography from the University of Connecticut.